abagovomab 38
abciximab 27
abituzumab 27
abrilumab 14
actoxumab 20
adalimumab 15
aducanumab 14
afasevikumab 12
alacizumab_pegol 9
alemtuzumab 30
alirocumab 18
amatuximab 44
andecaliximab 22
anifrolumab 22
anrukinzumab 17
aprutumab 17
aprutumab_ixadotin 17
arcitumomab 17
ascrinvacumab 7
atezolizumab 14
atinumab 17
avelumab 12
basiliximab 33
bavituximab 34
begelomab 33
benralizumab 26
bevacizumab_beta 22
bezlotoxumab 20
bimagrumab 18
bleselumab 21
blinatumomab 38
blosozumab 31
bococizumab 19
brazikumab 20
brentuximab_vedotin 28
briakinumab 21
brodalumab 13
brolucizumab 29
brontictuzumab 27
burosumab 20
cabiralizumab 28
camrelizumab 15
canakinumab 23
cantuzumab_ravtansin 38
carlumab 17
carotuximab 13
cergutuzumab_amunaleukin2 29
cergutuzumab_amunaleukin 29
certolizumab_pegol 27
cetiximab 38
citatuzumab_bogatox 28
cixutumumab 35
clivatuzumab_tetraxetan 21
codrituzumab 22
conatumumab 17
concizumab 21
crenezumab 19
crizanlizumab 26
crotedumab 20
dacetuzumab 22
daclizumab 16
dalotuzumab 27
dapirolizumab_pegol 26
daratumumab 14
dectrekumab 11
demcizumab 25
denosumab 8
depatuxizumab 22
depatuxizumab_mafodotin 22
dezamizumab 23
dinutuximab 37
diridavumab 23
domagrozumab 18
drozitumab 21
duligotuzumab 20
durvalumab 16
dusigitumab 24
efalizumab 37
efungumab 25
eldelumab 17
elezanumab 24
elgemtumab 10
elotuzumab 17
emactuzumab 20
emapalumab 28
emibetuzumab 22
enavatuzumab 25
enfortumab_vedotin 15
enoblituzumab 20
enokizumab 26
enoticumab 21
ensituximab 36
eptinezumab 15
erenumab 25
etaracizumab 17
etrolizumab 23
evinacumab 22
evolocumab 23
farletuzumab 3
fasinumab 23
fezakinumab 22
fibatuzumab 9
ficlatuzumab 25
firivumab 31
flanvotumab 23
fletikumab 25
foralumab 17
foravirumab 18
fremanezumab 32
fresolimumab 19
fulranumab 22
futuximab 21
galcanezumab 15
ganitumab 23
gantenerumab 14
gemetuzumab 29
gemtuzumab2 23
gemtuzumab 23
gevokizumab 25
girentuximab 27
glembatumumab 21
glembatumumab_vedotin 21
guselkumab 21
ibalizumab 33
ibritumomab 28
icrucumab 15
idarucizumab 28
ifabotuzumab 9
imalumab 15
imgatuzumab 22
inclacumab 24
indatuximab_ravtansin 29
indusatumab 21
inebilizumab 23
intetumumab 18
iodine_girentuximab 31
ipilimumab 5
iratumumab 11
isatuximab 35
itolizumab 26
ixekizumab 29
labetuzumab_govitecan 26
lambrolizumab 33
lampalizumab 25
lanadelumab 19
landogrozumab 16
laprituximab 32
lebrikizumab 30
lendalizumab 25
lenzilumab 22
lifastuzumab_vedotin 25
ligelizumab 23
lilotomab 36
lirilumab 24
lodelcizumab 16
lokivetmab 17
lorvotuzumab_mertansin 18
lucatumumab 31
lumretuzumab 22
lupartumab 20
lutikizumab 16
margetuximab 34
milatuzumab 31
mirvetuximab 39
mirvetuximab_soravtansin 39
modotuximab 44
mogamulizumab 22
monalizumab 23
motavizumab 31
moxetumomab_pasudotox 19
namilumab 23
naratuximab 31
naratuximab_emtansin 31
narnatumab 21
navicixizumab2 28
navicixizumab 27
navivumab 34
necitumumab 13
nemolizumab 27
nesvacumab 14
nivolumab 18
obiltoxaximab 21
obinutuzumab 30
ocaratuzumab 22
ofatumumab 16
olaratumab 23
olokizumab 24
omalizumab 18
onartuzumab 24
ontuxizumab 31
opicinumab 14
orticumab 12
otelixizumab 40
oxelumab 11
ozanezumab 25
pamrevlumab 12
panobacumab 19
parsatuzumab 32
pasotuxizumab 17
pateclizumab 16
patritumab 19
pembrolizumab 33
perakizumab 23
pidilizumab 16
pinatuzumab_vedotin 16
plozalizumab 23
pogalizumab 25
polatuzumab_vedotin 20
ponezumab 27
prezalumab 15
pritoxaximab 40
quilizumab 19
racotumomab 33
radretumab 17
ralpancizumab 24
ramucirumab 15
ranevetmab 29
ranibizumab 21
refanezumab 24
remtolumab 19
rilotumumab 17
rinucumab 19
risankizumab 32
rituximab 23
rivabazumab 24
robatumumab 21
roledumab 30
romosozumab 25
rontalizumab 23
rosmantuzumab 23
rozanolixizumab 22
sacituzumab 30
sacituzumab_govitecan 30
samalizumab 29
sapelizumab 22
sarilumab 17
secukinumab 18
seribantumab 19
setoxaximab 36
sifalimumab 13
siltuximab 22
simtuzumab 27
sirukumab 10
solanezumab 28
solitomab 27
stamulumab 21
suptavumab 24
suvizumab 15
tabalumab 23
tadocizumab 18
tamtuvetmab 30
tanezumab 25
tarextumab 12
tavolixizumab 12
telisotuzumab 32
teplizumab 19
tesidolumab 25
tezepelumab 27
tigatuzumab 16
tildrakizumab 24
timolumab 17
tisotumab 11
tosatoxumab 34
tositumomab 25
tralokinumab 36
trastuzumab 24
tregalizumab 21
trevogrumab 12
ublituximab 23
urelumab 15
ustekinumab 29
utomilumab 27
vadastuximab 27
vadastuximab_talirin 27
vandortuzumab_vedotin 22
vantictumab 27
vanucizumab2 22
vanucizumab 36
varlilumab 19
vatelizumab 25
vedolizumab 29
veltuzumab 11
vesencumab 10
vorsetuzumab 25
vorsetuzumab_mafodotin 25
vunakizumab 35
xentuzumab 20
zatuximab 44
